{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T13:29:05Z","timestamp":1768742945593,"version":"3.49.0"},"reference-count":213,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia (PT)","doi-asserted-by":"publisher","award":["SFRH\/BPD\/90673\/2012"],"award-info":[{"award-number":["SFRH\/BPD\/90673\/2012"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12920-016-0173-x","type":"journal-article","created":{"date-parts":[[2016,3,9]],"date-time":"2016-03-09T04:06:58Z","timestamp":1457496418000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Efficient and biologically relevant consensus strategy for Parkinson\u2019s disease gene prioritization"],"prefix":"10.1186","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4042-5794","authenticated-orcid":false,"given":"Maykel","family":"Cruz-Monteagudo","sequence":"first","affiliation":[]},{"given":"Fernanda","family":"Borges","sequence":"additional","affiliation":[]},{"given":"Cesar","family":"Paz-y-Mi\u00f1o","sequence":"additional","affiliation":[]},{"given":"M. Nat\u00e1lia D. S.","family":"Cordeiro","sequence":"additional","affiliation":[]},{"given":"Irene","family":"Rebelo","sequence":"additional","affiliation":[]},{"given":"Yunierkis","family":"Perez-Castillo","sequence":"additional","affiliation":[]},{"given":"Aliuska Morales","family":"Helguera","sequence":"additional","affiliation":[]},{"given":"Aminael","family":"S\u00e1nchez-Rodr\u00edguez","sequence":"additional","affiliation":[]},{"given":"Eduardo","family":"Tejera","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,3,9]]},"reference":[{"issue":"21 Suppl 4","key":"173_CR1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1212\/WNL.0b013e3181a1d44c","volume":"72","author":"CW Olanow","year":"2009","unstructured":"Olanow CW, Stern MB, Sethi K. The scientific and clinical basis for the treatment of Parkinson disease (2009). Neurology. 2009;72(21 Suppl 4):S1\u2013136.","journal-title":"Neurology"},{"issue":"7","key":"173_CR2","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1212\/01.WNL.0000140706.52798.BE","volume":"63","author":"LM Lau de","year":"2004","unstructured":"de Lau LM, Giesbergen PC, de Rijk MC, Hofman A, Koudstaal PJ, Breteler MM. Incidence of parkinsonism and Parkinson disease in a general population: the Rotterdam Study. Neurology. 2004;63(7):1240\u20134.","journal-title":"Neurology"},{"issue":"5","key":"173_CR3","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","volume":"68","author":"ER Dorsey","year":"2007","unstructured":"Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology. 2007;68(5):384\u20136.","journal-title":"Neurology"},{"issue":"7","key":"173_CR4","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1056\/NEJM196702162760703","volume":"276","author":"GC Cotzias","year":"1967","unstructured":"Cotzias GC, Van Woert MH, Schiffer LM. Aromatic amino acids and modification of parkinsonism. New Engl J Med. 1967;276(7):374\u20139.","journal-title":"New Engl J Med"},{"issue":"2","key":"173_CR5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging. 2003;24(2):197\u2013211.","journal-title":"Neurobiol Aging"},{"issue":"3","key":"173_CR6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archneur.60.3.337","volume":"60","author":"C Zarow","year":"2003","unstructured":"Zarow C, Lyness SA, Mortimer JA, Chui HC. Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Arch Neurol. 2003;60(3):337\u201341.","journal-title":"Arch Neurol"},{"issue":"2","key":"173_CR7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.parkreldis.2009.08.007","volume":"16","author":"CH Hawkes","year":"2010","unstructured":"Hawkes CH, Del Tredici K, Braak H. A timeline for Parkinson\u2019s disease. Parkinsonism Relat Disord. 2010;16(2):79\u201384.","journal-title":"Parkinsonism Relat Disord"},{"issue":"Pt 5","key":"173_CR8","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","volume":"114","author":"JM Fearnley","year":"1991","unstructured":"Fearnley JM, Lees AJ. Ageing and Parkinson\u2019s disease: substantia nigra regional selectivity. Brain. 1991;114(Pt 5):2283\u2013301.","journal-title":"Brain"},{"issue":"3","key":"173_CR9","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/mds.1099","volume":"16","author":"LM Shulman","year":"2001","unstructured":"Shulman LM, Taback RL, Bean J, Weiner WJ. Comorbidity of the nonmotor symptoms of Parkinson\u2019s disease. Mov Disord. 2001;16(3):507\u201310. doi: 10.1002\/mds.1099 .","journal-title":"Mov Disord"},{"issue":"3","key":"173_CR10","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nurx.2006.05.008","volume":"3","author":"RM Miller","year":"2006","unstructured":"Miller RM, Federoff HJ. Microarrays in Parkinson\u2019s disease: a systematic approach. NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics. 2006;3(3):319\u201326. doi: 10.1016\/j.nurx.2006.05.008 .","journal-title":"NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics"},{"key":"173_CR11","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015. doi: 10.1093\/nar\/gkv007 .","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"173_CR12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/gbb.12106","volume":"13","author":"C Gaiteri","year":"2014","unstructured":"Gaiteri C, Ding Y, French B, Tseng GC, Sibille E. Beyond modules and hubs: the potential of gene coexpression networks for investigating molecular mechanisms of complex brain disorders. Genes Brain Behav. 2014;13(1):13\u201324. doi: 10.1111\/gbb.12106 .","journal-title":"Genes Brain Behav"},{"key":"173_CR13","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1186\/1471-2164-9-S1-S13","volume":"9 Suppl 1","author":"M Pirooznia","year":"2008","unstructured":"Pirooznia M, Yang JY, Yang MQ, Deng Y. A comparative study of different machine learning methods on microarray gene expression data. BMC Genomics. 2008;9 Suppl 1:S13. doi: 10.1186\/1471-2164-9-s1-s13 .","journal-title":"BMC Genomics"},{"issue":"6","key":"173_CR14","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.conb.2012.05.007","volume":"22","author":"P Cisek","year":"2012","unstructured":"Cisek P. Making decisions through a distributed consensus. Curr Opin Neurobiol. 2012;22(6):927\u201336. doi: 10.1016\/j.conb.2012.05.007 .","journal-title":"Curr Opin Neurobiol"},{"issue":"6","key":"173_CR15","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/ni.2587","volume":"14","author":"V Jojic","year":"2013","unstructured":"Jojic V, Shay T, Sylvia K, Zuk O, Sun X, Kang J, et al. Identification of transcriptional regulators in the mouse immune system. Nat Immunol. 2013;14(6):633\u201343. doi: 10.1038\/ni.2587 .","journal-title":"Nat Immunol"},{"issue":"5","key":"173_CR16","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/wsbm.1177","volume":"4","author":"NT Doncheva","year":"2012","unstructured":"Doncheva NT, Kacprowski T, Albrecht M. Recent approaches to the prioritization of candidate disease genes. Wiley Interdiscip Rev Syst Biol Med. 2012;4(5):429\u201342. doi: 10.1002\/wsbm.1177 .","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"issue":"2","key":"173_CR17","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1021\/ci600426e","volume":"47","author":"JF Truchon","year":"2007","unstructured":"Truchon JF, Bayly CI. Evaluating virtual screening methods: good and bad metrics for the \u201cearly recognition\u201d problem. J Chem Inf Model. 2007;47(2):488\u2013508. doi: 10.1021\/ci600426e .","journal-title":"J Chem Inf Model"},{"issue":"Database issue","key":"173_CR18","doi-asserted-by":"crossref","first-page":"D1005","DOI":"10.1093\/nar\/gkq1184","volume":"39","author":"T Barrett","year":"2011","unstructured":"Barrett T, Troup DB, Wilhite SE, Ledoux P, Evangelista C, Kim IF, et al. NCBI GEO: archive for functional genomics data sets\u201410\u00a0years on. Nucleic Acids Res. 2011;39(Database issue):D1005\u201310. doi: 10.1093\/nar\/gkq1184 .","journal-title":"Nucleic Acids Res"},{"issue":"14","key":"173_CR19","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1093\/bioinformatics\/btm254","volume":"23","author":"S Davis","year":"2007","unstructured":"Davis S, Meltzer PS. GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor. Bioinformatics. 2007;23(14):1846\u20137. doi: 10.1093\/bioinformatics\/btm254 .","journal-title":"Bioinformatics"},{"key":"173_CR20","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1186\/1471-2105-12-467","volume":"12","author":"J Rudy","year":"2011","unstructured":"Rudy J, Valafar F. Empirical comparison of cross-platform normalization methods for gene expression data. BMC Bioinformatics. 2011;12:467. doi: 10.1186\/1471-2105-12-467 .","journal-title":"BMC Bioinformatics"},{"issue":"11","key":"173_CR21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013822","volume":"5","author":"A Sirbu","year":"2010","unstructured":"Sirbu A, Ruskin HJ, Crane M. Cross-platform microarray data normalisation for regulatory network inference. PLoS One. 2010;5(11), e13822. doi: 10.1371\/journal.pone.0013822 .","journal-title":"PLoS One"},{"issue":"1","key":"173_CR22","volume":"6","author":"X Fan","year":"2011","unstructured":"Fan X, Shao L, Fang H, Tong W, Cheng Y. Cross-platform comparison of microarray-based multiple-class prediction. PLoS One. 2011;6(1), e16067. doi: 10.1371\/journal.pone.0016067 .","journal-title":"PLoS One"},{"key":"173_CR23","unstructured":"Carlson M. hgfocus.db: Affymetrix Human Genome Focus Array annotation data (chip hgfocus). R package version 3.0.0."},{"key":"173_CR24","unstructured":"Carlson M. hgu133plus2.db: Affymetrix Human Genome U133 Plus 2.0 Array annotation data (chip hgu133plus2). R package version 3.0.0."},{"key":"173_CR25","unstructured":"Carlson M. hgu133a.db: Affymetrix Human Genome U133 Set annotation data (chip hgu133a). R package version 3.0.0."},{"key":"173_CR26","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/1471-2105-12-322","volume":"12","author":"JA Miller","year":"2011","unstructured":"Miller JA, Cai C, Langfelder P, Geschwind DH, Kurian SM, Salomon DR, et al. Strategies for aggregating gene expression data: the collapseRows R function. BMC Bioinformatics. 2011;12:322. doi: 10.1186\/1471-2105-12-322 .","journal-title":"BMC Bioinformatics"},{"key":"173_CR27","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559. doi: 10.1186\/1471-2105-9-559 .","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"173_CR28","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","volume":"8","author":"WE Johnson","year":"2007","unstructured":"Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007;8(1):118\u201327. doi: 10.1093\/biostatistics\/kxj037 .","journal-title":"Biostatistics"},{"key":"173_CR29","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/0-387-29362-0_23","volume-title":"Bioinformatics and computational biology solutions using R and bioconductor. Statistics for biology and health","author":"GK Smyth","year":"2005","unstructured":"Smyth GK. limma: Linear Models for Microarray Data. In: Gentleman R, Carey V, Huber W, Irizarry R, Dudoit S, editors. Bioinformatics and computational biology solutions using R and bioconductor. Statistics for biology and health. New York: Springer; 2005. p. 397\u2013420."},{"issue":"1","key":"173_CR30","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol. 1995;57(1):289\u2013300. doi: 10.2307\/2346101 .","journal-title":"J R Stat Soc Ser B Methodol"},{"key":"173_CR31","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/minf.201000061","volume":"29","author":"A Tropsha","year":"2010","unstructured":"Tropsha A. Best practices for QSAR model development, validation, and exploitation. Mol Inf. 2010;29:476\u201388. doi: 10.1002\/minf.201000061 .","journal-title":"Mol Inf"},{"key":"173_CR32","volume-title":"STATISTICA. version 8.0 ed","author":"StatSoft","year":"2007","unstructured":"StatSoft. STATISTICA. version 8.0 ed. 2007. p. (data analysis software system)."},{"issue":"8","key":"173_CR33","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1109\/TPAMI.2005.159","volume":"27","author":"H Peng","year":"2005","unstructured":"Peng H, Long F, Ding C. Feature selection based on mutual information: criteria of max-dependency, max-relevance, and min-redundancy. IEEE Trans Pattern Anal Machine Intel. 2005;27(8):1226\u201338.","journal-title":"IEEE Trans Pattern Anal Machine Intel"},{"key":"173_CR34","volume-title":"Waikato Environment for Knowledge Analysis (WEKA). 3.7.11 ed","author":"WEKA","year":"2014","unstructured":"WEKA. Waikato Environment for Knowledge Analysis (WEKA). 3.7.11 ed. New Zealand: University of Waikato; 2014."},{"key":"173_CR35","doi-asserted-by":"crossref","first-page":"Article17","DOI":"10.2202\/1544-6115.1128","volume":"4","author":"B Zhang","year":"2005","unstructured":"Zhang B, Horvath S. A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol. 2005;4:Article17. doi: 10.2202\/1544-6115.1128 .","journal-title":"Stat Appl Genet Mol Biol"},{"issue":"5","key":"173_CR36","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/bioinformatics\/btm563","volume":"24","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Zhang B, Horvath S. Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R. Bioinformatics. 2008;24(5):719\u201320. doi: 10.1093\/bioinformatics\/btm563 .","journal-title":"Bioinformatics"},{"key":"173_CR37","first-page":"51","volume":"6","author":"E Tejera","year":"2013","unstructured":"Tejera E, Bernardes J, Rebelo I. Co-expression network analysis and genetic algorithms for gene prioritization in preeclampsia. BMC Med Genet. 2013;6:51. doi: 10.1186\/1755-8794-6-51 .","journal-title":"BMC Med Genet"},{"issue":"1","key":"173_CR38","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W Huang da","year":"2009","unstructured":"da Huang W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44\u201357. doi: 10.1038\/nprot.2008.211 .","journal-title":"Nat Protoc"},{"issue":"Database issue","key":"173_CR39","doi-asserted-by":"crossref","first-page":"D1057","DOI":"10.1093\/nar\/gku1113","volume":"43","author":"RP Huntley","year":"2015","unstructured":"Huntley RP, Sawford T, Mutowo-Meullenet P, Shypitsyna A, Bonilla C, Martin MJ, et al. The GOA database: Gene Ontology annotation updates for 2015. Nucleic Acids Res. 2015;43(Database issue):D1057\u201363. doi: 10.1093\/nar\/gku1113 .","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"173_CR40","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/ng0504-431","volume":"36","author":"KG Becker","year":"2004","unstructured":"Becker KG, Barnes KC, Bright TJ, Wang SA. The genetic association database. Nat Genet. 2004;36(5):431\u20132. doi: 10.1038\/ng0504-431 .","journal-title":"Nat Genet"},{"issue":"Web Server issu","key":"173_CR41","doi-asserted-by":"crossref","first-page":"W96","DOI":"10.1093\/nar\/gkq418","volume":"38","author":"V Kaimal","year":"2010","unstructured":"Kaimal V, Bardes EE, Tabar SC, Jegga AG, Aronow BJ. ToppCluster: a multiple gene list feature analyzer for comparative enrichment clustering and network-based dissection of biological systems. Nucleic Acids Res. 2010;38(Web Server issue):W96\u2013102. doi: 10.1093\/nar\/gkq418 .","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"173_CR42","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/amiajnl-2011-000658","volume":"19","author":"X Liu","year":"2012","unstructured":"Liu X, Liu ZP, Zhao XM, Chen L. Identifying disease genes and module biomarkers by differential interactions. J Am Med Inform Assoc. 2012;19(2):241\u20138. doi: 10.1136\/amiajnl-2011-000658 .","journal-title":"J Am Med Inform Assoc"},{"issue":"4","key":"173_CR43","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/amiajnl-2012-001168","volume":"20","author":"Z Wen","year":"2013","unstructured":"Wen Z, Liu ZP, Liu Z, Zhang Y, Chen L. An integrated approach to identify causal network modules of complex diseases with application to colorectal cancer. J Am Med Inform Assoc. 2013;20(4):659\u201367. doi: 10.1136\/amiajnl-2012-001168 .","journal-title":"J Am Med Inform Assoc"},{"issue":"5","key":"173_CR44","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1021\/ci8003978","volume":"49","author":"MD Mackey","year":"2009","unstructured":"Mackey MD, Melville JL. Better than random? The chemotype enrichment problem. J Chem Inf Model. 2009;49(5):1154\u201362. doi: 10.1021\/ci8003978 .","journal-title":"J Chem Inf Model"},{"issue":"52","key":"173_CR45","doi-asserted-by":"crossref","first-page":"52ra73","DOI":"10.1126\/scitranslmed.3001059","volume":"2","author":"B Zheng","year":"2010","unstructured":"Zheng B, Liao Z, Locascio JJ, Lesniak KA, Roderick SS, Watt ML, et al. PGC-1alpha, a potential therapeutic target for early intervention in Parkinson\u2019s disease. Sci Transl Med. 2010;2(52):52ra73. doi: 10.1126\/scitranslmed.3001059 .","journal-title":"Sci Transl Med"},{"issue":"6","key":"173_CR46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.0030098","volume":"3","author":"TG Lesnick","year":"2007","unstructured":"Lesnick TG, Papapetropoulos S, Mash DC, Ffrench-Mullen J, Shehadeh L, de Andrade M, et al. A genomic pathway approach to a complex disease: axon guidance and Parkinson disease. PLoS Genet. 2007;3(6), e98. doi: 10.1371\/journal.pgen.0030098 .","journal-title":"PLoS Genet"},{"issue":"1","key":"173_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10048-005-0020-2","volume":"7","author":"LB Moran","year":"2006","unstructured":"Moran LB, Duke DC, Deprez M, Dexter DT, Pearce RK, Graeber MB. Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson\u2019s disease. Neurogenetics. 2006;7(1):1\u201311. doi: 10.1007\/s10048-005-0020-2 .","journal-title":"Neurogenetics"},{"issue":"12","key":"173_CR48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052319","volume":"7","author":"H Diao","year":"2012","unstructured":"Diao H, Li X, Hu S, Liu Y. Gene expression profiling combined with bioinformatics analysis identify biomarkers for Parkinson disease. PLoS One. 2012;7(12), e52319. doi: 10.1371\/journal.pone.0052319 .","journal-title":"PLoS One"},{"issue":"12","key":"173_CR49","doi-asserted-by":"crossref","first-page":"10881","DOI":"10.1007\/s11033-012-1985-1","volume":"39","author":"B Zhang","year":"2012","unstructured":"Zhang B, Xia C, Lin Q, Huang J. Identification of key pathways and transcription factors related to Parkinson disease in genome wide. Mol Biol Rep. 2012;39(12):10881\u20137. doi: 10.1007\/s11033-012-1985-1 .","journal-title":"Mol Biol Rep"},{"issue":"8","key":"173_CR50","volume":"10","author":"X Su","year":"2015","unstructured":"Su X, Chu Y, Kordower JH, Li B, Cao H, Huang L, et al. PGC-1alpha Promoter Methylation in Parkinson\u2019s Disease. PLoS One. 2015;10(8), e0134087. doi: 10.1371\/journal.pone.0134087 .","journal-title":"PLoS One"},{"key":"173_CR51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2014.11.002","volume":"74","author":"E Glaab","year":"2015","unstructured":"Glaab E, Schneider R. Comparative pathway and network analysis of brain transcriptome changes during adult aging and in Parkinson\u2019s disease. Neurobiol Dis. 2015;74:1\u201313. doi: 10.1016\/j.nbd.2014.11.002 .","journal-title":"Neurobiol Dis"},{"issue":"3","key":"173_CR52","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00401-009-0560-x","volume":"118","author":"NL Lehman","year":"2009","unstructured":"Lehman NL. The ubiquitin proteasome system in neuropathology. Acta Neuropathol. 2009;118(3):329\u201347. doi: 10.1007\/s00401-009-0560-x .","journal-title":"Acta Neuropathol"},{"issue":"1","key":"173_CR53","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ajmg.b.30195","volume":"137B","author":"Y Zhang","year":"2005","unstructured":"Zhang Y, James M, Middleton FA, Davis RL. Transcriptional analysis of multiple brain regions in Parkinson\u2019s disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms. Am J Med Genet B Neuropsychiatr Genet. 2005;137B(1):5\u201316. doi: 10.1002\/ajmg.b.30195 .","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"8","key":"173_CR54","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1001\/archneur.65.8.1074","volume":"65","author":"A DelleDonne","year":"2008","unstructured":"DelleDonne A, Klos KJ, Fujishiro H, Ahmed Z, Parisi JE, Josephs KA, et al. Incidental Lewy body disease and preclinical Parkinson disease. Arch Neurol. 2008;65(8):1074\u201380. doi: 10.1001\/archneur.65.8.1074 .","journal-title":"Arch Neurol"},{"issue":"4","key":"173_CR55","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1080\/00224065.1980.11980968","volume":"12","author":"G Derringer","year":"1980","unstructured":"Derringer G, Suich R. Simultaneous optimization of several response variables. J Quality Technol. 1980;12(4):214\u20139.","journal-title":"J Quality Technol"},{"issue":"6684","key":"173_CR56","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/30918","volume":"393","author":"DJ Watts","year":"1998","unstructured":"Watts DJ, Strogatz SH. Collective dynamics of \u2018small-world\u2019 networks. Nature. 1998;393(6684):440\u20132. doi: 10.1038\/30918 .","journal-title":"Nature"},{"issue":"6833","key":"173_CR57","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/35075138","volume":"411","author":"H Jeong","year":"2001","unstructured":"Jeong H, Mason SP, Barabasi AL, Oltvai ZN. Lethality and centrality in protein networks. Nature. 2001;411(6833):41\u20132. doi: 10.1038\/35075138 .","journal-title":"Nature"},{"key":"173_CR58","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/1471-2105-6-227","volume":"6","author":"CJ Wolfe","year":"2005","unstructured":"Wolfe CJ, Kohane IS, Butte AJ. Systematic survey reveals general applicability of \u201cguilt-by-association\u201d within gene coexpression networks. BMC Bioinformatics. 2005;6:227. doi: 10.1186\/1471-2105-6-227 .","journal-title":"BMC Bioinformatics"},{"issue":"3","key":"173_CR59","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","volume":"54","author":"AH Schapira","year":"1990","unstructured":"Schapira AH, Cooper JM, Dexter D, Clark JB, Jenner P, Marsden CD. Mitochondrial complex I deficiency in Parkinson\u2019s disease. J Neurochem. 1990;54(3):823\u20137.","journal-title":"J Neurochem"},{"issue":"3","key":"173_CR60","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/ana.410300304","volume":"30","author":"JM Shoffner","year":"1991","unstructured":"Shoffner JM, Watts RL, Juncos JL, Torroni A, Wallace DC. Mitochondrial oxidative phosphorylation defects in Parkinson\u2019s disease. Ann Neurol. 1991;30(3):332\u20139. doi: 10.1002\/ana.410300304 .","journal-title":"Ann Neurol"},{"issue":"9","key":"173_CR61","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.freeradbiomed.2012.08.569","volume":"53","author":"R Perfeito","year":"2012","unstructured":"Perfeito R, Cunha-Oliveira T, Rego AC. Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease\u2013resemblance to the effect of amphetamine drugs of abuse. Free Radic Biol Med. 2012;53(9):1791\u2013806. doi: 10.1016\/j.freeradbiomed.2012.08.569 .","journal-title":"Free Radic Biol Med"},{"key":"173_CR62","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pneurobio.2013.04.004","volume":"106\u2013107","author":"SR Subramaniam","year":"2013","unstructured":"Subramaniam SR, Chesselet MF. Mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease. Prog Neurobiol. 2013;106\u2013107:17\u201332. doi: 10.1016\/j.pneurobio.2013.04.004 .","journal-title":"Prog Neurobiol"},{"key":"173_CR63","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.nbd.2012.10.011","volume":"51","author":"DN Hauser","year":"2013","unstructured":"Hauser DN, Hastings TG. Mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease and monogenic parkinsonism. Neurobiol Dis. 2013;51:35\u201342. doi: 10.1016\/j.nbd.2012.10.011 .","journal-title":"Neurobiol Dis"},{"issue":"2","key":"173_CR64","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bbadis.2011.10.002","volume":"1822","author":"L Breydo","year":"2012","unstructured":"Breydo L, Wu JW, Uversky VN. \u03b1-Synuclein misfolding and Parkinson\u2019s disease. Biochim Biophys Acta (BBA) - Mol Basis Dis. 2012;1822(2):261\u201385. http:\/\/dx.doi.org\/10.1016\/j.bbadis.2011.10.002 .","journal-title":"Biochim Biophys Acta (BBA) - Mol Basis Dis"},{"issue":"5\u20136","key":"173_CR65","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.cca.2009.12.002","volume":"411","author":"CM Chen","year":"2010","unstructured":"Chen CM, Lee LC, Soong BW, Fung HC, Hsu WC, Lin PY, et al. SCA17 repeat expansion: mildly expanded CAG\/CAA repeat alleles in neurological disorders and the functional implications. Clin Chim Acta. 2010;411(5\u20136):375\u201380. doi: 10.1016\/j.cca.2009.12.002 .","journal-title":"Clin Chim Acta"},{"issue":"3\u20134","key":"173_CR66","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10822-007-9163-6","volume":"22","author":"J Kirchmair","year":"2008","unstructured":"Kirchmair J, Markt P, Distinto S, Wolber G, Langer T. Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection\u2013what can we learn from earlier mistakes? J Comput-Aided Mol Design. 2008;22(3\u20134):213\u201328. doi: 10.1007\/s10822-007-9163-6 .","journal-title":"J Comput-Aided Mol Design"},{"key":"173_CR67","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.arr.2013.12.009","volume":"13","author":"M Bisaglia","year":"2014","unstructured":"Bisaglia M, Filograna R, Beltramini M, Bubacco L. Are dopamine derivatives implicated in the pathogenesis of Parkinson\u2019s disease? Ageing Res Rev. 2014;13:107\u201314. doi: 10.1016\/j.arr.2013.12.009 .","journal-title":"Ageing Res Rev"},{"issue":"7","key":"173_CR68","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1021\/tx9000557","volume":"22","author":"JN Rees","year":"2009","unstructured":"Rees JN, Florang VR, Eckert LL, Doorn JA. Protein reactivity of 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite, is dependent on both the aldehyde and the catechol. Chem Res Toxicol. 2009;22(7):1256\u201363. doi: 10.1021\/tx9000557 .","journal-title":"Chem Res Toxicol"},{"issue":"2","key":"173_CR69","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1124\/pr.59.2.1","volume":"59","author":"SA Marchitti","year":"2007","unstructured":"Marchitti SA, Deitrich RA, Vasiliou V. Neurotoxicity and metabolism of the catecholamine-derived 3,4-dihydroxyphenylacetaldehyde and 3,4-dihydroxyphenylglycolaldehyde: the role of aldehyde dehydrogenase. Pharmacol Rev. 2007;59(2):125\u201350. doi: 10.1124\/pr.59.2.1 .","journal-title":"Pharmacol Rev"},{"issue":"2","key":"173_CR70","volume":"7","author":"MC Wey","year":"2012","unstructured":"Wey MC, Fernandez E, Martinez PA, Sullivan P, Goldstein DS, Strong R. Neurodegeneration and motor dysfunction in mice lacking cytosolic and mitochondrial aldehyde dehydrogenases: implications for Parkinson\u2019s disease. PLoS One. 2012;7(2), e31522. doi: 10.1371\/journal.pone.0031522 .","journal-title":"PLoS One"},{"issue":"1\u20132","key":"173_CR71","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cbi.2011.01.006","volume":"192","author":"Y Jinsmaa","year":"2011","unstructured":"Jinsmaa Y, Florang VR, Rees JN, Mexas LM, Eckert LL, Allen EM, et al. Dopamine-derived biological reactive intermediates and protein modifications: implications for Parkinson\u2019s disease. Chem Biol Interact. 2011;192(1\u20132):118\u201321. doi: 10.1016\/j.cbi.2011.01.006 .","journal-title":"Chem Biol Interact"},{"issue":"3","key":"173_CR72","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1124\/pr.56.3.1","volume":"56","author":"G Eisenhofer","year":"2004","unstructured":"Eisenhofer G, Kopin IJ, Goldstein DS. Catecholamine metabolism: a contemporary view with implications for physiology and medicine. Pharmacol Rev. 2004;56(3):331\u201349. doi: 10.1124\/pr.56.3.1 .","journal-title":"Pharmacol Rev"},{"issue":"4","key":"173_CR73","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0028-3908(86)90242-X","volume":"25","author":"B Fornstedt","year":"1986","unstructured":"Fornstedt B, Rosengren E, Carlsson A. Occurrence and distribution of 5-S-cysteinyl derivatives of dopamine, dopa and dopac in the brains of eight mammalian species. Neuropharmacology. 1986;25(4):451\u20134.","journal-title":"Neuropharmacology"},{"issue":"2","key":"173_CR74","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0891-5849(94)00141-6","volume":"18","author":"A Klegeris","year":"1995","unstructured":"Klegeris A, Korkina LG, Greenfield SA. Autoxidation of dopamine: a comparison of luminescent and spectrophotometric detection in basic solutions. Free Radic Biol Med. 1995;18(2):215\u201322.","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"173_CR75","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1073\/pnas.93.5.1956","volume":"93","author":"TG Hastings","year":"1996","unstructured":"Hastings TG, Lewis DA, Zigmond MJ. Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc Natl Acad Sci U S A. 1996;93(5):1956\u201361.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6701","key":"173_CR76","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/26652","volume":"395","author":"E Leroy","year":"1998","unstructured":"Leroy E, Boyer R, Auburger G, Leube B, Ulm G, Mezey E, et al. The ubiquitin pathway in Parkinson\u2019s disease. Nature. 1998;395(6701):451\u20132. doi: 10.1038\/26652 .","journal-title":"Nature"},{"issue":"6676","key":"173_CR77","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/33416","volume":"392","author":"T Kitada","year":"1998","unstructured":"Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 1998;392(6676):605\u20138. doi: 10.1038\/33416 .","journal-title":"Nature"},{"issue":"5688","key":"173_CR78","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1126\/science.1101738","volume":"305","author":"AM Cuervo","year":"2004","unstructured":"Cuervo AM, Stefanis L, Fredenburg R, Lansbury PT, Sulzer D. Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science. 2004;305(5688):1292\u20135. doi: 10.1126\/science.1101738 .","journal-title":"Science"},{"issue":"Suppl 1","key":"173_CR79","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.parkreldis.2004.10.013","volume":"11","author":"EC Hirsch","year":"2005","unstructured":"Hirsch EC, Hunot S, Hartmann A. Neuroinflammatory processes in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2005;11 Suppl 1:S9\u201315. doi: 10.1016\/j.parkreldis.2004.10.013 .","journal-title":"Parkinsonism Relat Disord"},{"key":"173_CR80","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1749-6632.2003.tb07470.x","volume":"991","author":"MF Beal","year":"2003","unstructured":"Beal MF. Mitochondria, oxidative damage, and inflammation in Parkinson\u2019s disease. Ann N Y Acad Sci. 2003;991:120\u201331.","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"173_CR81","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1001\/archpsyc.1992.01820030038005","volume":"49","author":"DL Braff","year":"1992","unstructured":"Braff DL, Grillon C, Geyer MA. Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiatry. 1992;49(3):206\u201315.","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"173_CR82","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/oxfordjournals.schbul.a033326","volume":"24","author":"NR Swerdlow","year":"1998","unstructured":"Swerdlow NR, Geyer MA. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr Bull. 1998;24(2):285\u2013301.","journal-title":"Schizophr Bull"},{"issue":"12","key":"173_CR83","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/archneur.1996.00550120077019","volume":"53","author":"JR Sanchez-Ramos","year":"1996","unstructured":"Sanchez-Ramos JR, Ortoll R, Paulson GW. Visual hallucinations associated with Parkinson disease. Arch Neurol. 1996;53(12):1265\u20138.","journal-title":"Arch Neurol"},{"issue":"Pt 4","key":"173_CR84","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/brain\/123.4.733","volume":"123","author":"G Fenelon","year":"2000","unstructured":"Fenelon G, Mahieux F, Huon R, Ziegler M. Hallucinations in Parkinson\u2019s disease: prevalence, phenomenology and risk factors. Brain. 2000;123(Pt 4):733\u201345.","journal-title":"Brain"},{"issue":"Suppl 2","key":"173_CR85","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.3949\/ccjm.79.s2a.03","volume":"79","author":"HH Fernandez","year":"2012","unstructured":"Fernandez HH. Nonmotor complications of Parkinson disease. Cleve Clin J Med. 2012;79 Suppl 2:S14\u20138. doi: 10.3949\/ccjm.79.s2a.03 .","journal-title":"Cleve Clin J Med"},{"issue":"4","key":"173_CR86","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1155\/2013\/902016","volume":"26","author":"H Alobaidi","year":"2013","unstructured":"Alobaidi H, Pall H. The role of dopamine replacement on the behavioural phenotype of Parkinson\u2019s disease. Behav Neurol. 2013;26(4):225\u201335. doi: 10.3233\/ben-2012-120265 .","journal-title":"Behav Neurol"},{"issue":"3","key":"173_CR87","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1212\/WNL.48.3.650","volume":"48","author":"JM Gorell","year":"1997","unstructured":"Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Kortsha GX, Brown GG, et al. Occupational exposures to metals as risk factors for Parkinson\u2019s disease. Neurology. 1997;48(3):650\u20138.","journal-title":"Neurology"},{"issue":"1","key":"173_CR88","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/mds.870080116","volume":"8","author":"BA Rybicki","year":"1993","unstructured":"Rybicki BA, Johnson CC, Uman J, Gorell JM. Parkinson\u2019s disease mortality and the industrial use of heavy metals in Michigan. Mov Disord. 1993;8(1):87\u201392. doi: 10.1002\/mds.870080116 .","journal-title":"Mov Disord"},{"issue":"2","key":"173_CR89","first-page":"159","volume":"38","author":"J Zayed","year":"1990","unstructured":"Zayed J, Campanella G, Panisset JC, Ducic S, Andre P, Masson H, et al. Parkinson disease and environmental factors. Rev Epidemiol Sante Publique. 1990;38(2):159\u201360.","journal-title":"Rev Epidemiol Sante Publique"},{"issue":"3","key":"173_CR90","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1017\/S0317167100030584","volume":"17","author":"J Zayed","year":"1990","unstructured":"Zayed J, Ducic S, Campanella G, Panisset JC, Andre P, Masson H, et al. Environmental factors in the etiology of Parkinson\u2019s disease. Can J Neurol Sci. 1990;17(3):286\u201391.","journal-title":"Can J Neurol Sci"},{"issue":"1","key":"173_CR91","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1054\/mehy.1997.0701","volume":"53","author":"E Altschuler","year":"1999","unstructured":"Altschuler E. Aluminum-containing antacids as a cause of idiopathic Parkinson\u2019s disease. Med Hypotheses. 1999;53(1):22\u20133. doi: 10.1054\/mehy.1997.0701 .","journal-title":"Med Hypotheses"},{"issue":"2\u20133","key":"173_CR92","first-page":"239","volume":"20","author":"JM Gorell","year":"1999","unstructured":"Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Kortsha GX, Brown GG, et al. Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson\u2019s disease. Neurotoxicology. 1999;20(2\u20133):239\u201347.","journal-title":"Neurotoxicology"},{"issue":"6","key":"173_CR93","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000026225","volume":"18","author":"JM Gorell","year":"1999","unstructured":"Gorell JM, Rybicki BA, Cole Johnson C, Peterson EL. Occupational metal exposures and the risk of Parkinson\u2019s disease. Neuroepidemiology. 1999;18(6):303\u20138.","journal-title":"Neuroepidemiology"},{"issue":"Pt 4","key":"173_CR94","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/brain\/114.4.1953","volume":"114","author":"DT Dexter","year":"1991","unstructured":"Dexter DT, Carayon A, Javoy-Agid F, Agid Y, Wells FR, Daniel SE, et al. Alterations in the levels of iron, ferritin and other trace metals in Parkinson\u2019s disease and other neurodegenerative diseases affecting the basal ganglia. Brain. 1991;114(Pt 4):1953\u201375.","journal-title":"Brain"},{"issue":"2","key":"173_CR95","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1471-4159.1989.tb09150.x","volume":"52","author":"P Riederer","year":"1989","unstructured":"Riederer P, Sofic E, Rausch WD, Schmidt B, Reynolds GP, Jellinger K, et al. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J Neurochem. 1989;52(2):515\u201320.","journal-title":"J Neurochem"},{"issue":"2","key":"173_CR96","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1471-4159.1991.tb08170.x","volume":"56","author":"EC Hirsch","year":"1991","unstructured":"Hirsch EC, Brandel JP, Galle P, Javoy-Agid F, Agid Y. Iron and aluminum increase in the substantia nigra of patients with Parkinson\u2019s disease: an X-ray microanalysis. J Neurochem. 1991;56(2):446\u201351.","journal-title":"J Neurochem"},{"key":"173_CR97","volume-title":"Gene expression profiling of parkinsonian substantia nigra (Expression profiling by array, Homo sapiens)","author":"J Jacob","year":"2013","unstructured":"Jacob J. Gene expression profiling of parkinsonian substantia nigra (Expression profiling by array, Homo sapiens). 2013."},{"issue":"Database issue","key":"173_CR98","doi-asserted-by":"crossref","first-page":"D447","DOI":"10.1093\/nar\/gku1003","volume":"43","author":"D Szklarczyk","year":"2015","unstructured":"Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015;43(Database issue):D447\u201352. doi: 10.1093\/nar\/gku1003 .","journal-title":"Nucleic Acids Res"},{"issue":"18","key":"173_CR99","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1093\/nar\/28.18.3442","volume":"28","author":"B Snel","year":"2000","unstructured":"Snel B, Lehmann G, Bork P, Huynen MA. STRING: a web-server to retrieve and display the repeatedly occurring neighbourhood of a gene. Nucleic Acids Res. 2000;28(18):3442\u20134.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"173_CR100","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498\u2013504. doi: 10.1101\/gr.1239303 .","journal-title":"Genome Res"},{"key":"173_CR101","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1186\/1471-2091-8-S1-S13","volume":"8 Suppl 1","author":"KL Lim","year":"2007","unstructured":"Lim KL, Tan JM. Role of the ubiquitin proteasome system in Parkinson\u2019s disease. BMC Biochem. 2007;8 Suppl 1:S13. doi: 10.1186\/1471-2091-8-s1-s13 .","journal-title":"BMC Biochem"},{"issue":"6","key":"173_CR102","volume":"9","author":"HJ Kim","year":"2014","unstructured":"Kim HJ, Kim HJ, Jeong JE, Baek JY, Jeong J, Kim S, et al. N-terminal truncated UCH-L1 prevents Parkinson\u2019s disease associated damage. PLoS One. 2014;9(6), e99654. doi: 10.1371\/journal.pone.0099654 .","journal-title":"PLoS One"},{"issue":"4","key":"173_CR103","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10048-015-0449-x","volume":"16","author":"V Cognata La","year":"2015","unstructured":"La Cognata V, D\u2019Agata V, Cavalcanti F, Cavallaro S. Splicing: is there an alternative contribution to Parkinson\u2019s disease? Neurogenetics. 2015;16(4):245\u201363. doi: 10.1007\/s10048-015-0449-x .","journal-title":"Neurogenetics"},{"key":"173_CR104","first-page":"675","volume-title":"9th European Conference on Principles and Practice of Knowledge Discovery in Databases; October 3\u20137; Porto, Portugal","author":"N Landwehr","year":"2005","unstructured":"Landwehr N, Hall M, Frank E. Speeding up logistic model tree induction. In: Sumner M, Frank E, Hall M, editors. 9th European Conference on Principles and Practice of Knowledge Discovery in Databases; October 3\u20137; Porto, Portugal. 2005. p. 675\u201383."},{"key":"173_CR105","first-page":"109","volume-title":"The rough set based rule induction technique for classification problems. 6th European Congress on Intelligent Techniques and Soft Computing; September 7\u201310; Aachen, Germany","author":"J Stefanowski","year":"1998","unstructured":"Stefanowski J. The rough set based rule induction technique for classification problems. 6th European Congress on Intelligent Techniques and Soft Computing; September 7\u201310; Aachen, Germany. 1998. p. 109\u201313."},{"key":"173_CR106","first-page":"144","volume-title":"Generating accurate rule sets without global optimization. Fifteenth International Conference on Machine Learning; July 24\u201326; Madison, Wisconsin, USA","author":"E Frank","year":"1998","unstructured":"Frank E, Witten IH. Generating accurate rule sets without global optimization. Fifteenth International Conference on Machine Learning; July 24\u201326; Madison, Wisconsin, USA. 1998. p. 144\u201351."},{"key":"173_CR107","first-page":"124","volume-title":"The alternating decision tree learning algorithm. Sixteenth International Conference on Machine Learning; June 27\u201330; Bled, Slovenia","author":"Y Freund","year":"1999","unstructured":"Freund Y, Mason L. The alternating decision tree learning algorithm. Sixteenth International Conference on Machine Learning; June 27\u201330; Bled, Slovenia. 1999. p. 124\u201333."},{"issue":"2","key":"173_CR108","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1214\/aos\/1016218223","volume":"28","author":"J Friedman","year":"2000","unstructured":"Friedman J, Hastie T, Tibshirani R. Additive logistic regression : a statistical view of boosting. Ann Stat. 2000;28(2):337\u2013407.","journal-title":"Ann Stat"},{"issue":"3","key":"173_CR109","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1023\/B:MACH.0000027782.67192.13","volume":"55","author":"J Gama","year":"2004","unstructured":"Gama J. Functional trees. Mach Learn. 2004;55(3):219\u201350.","journal-title":"Mach Learn"},{"key":"173_CR110","first-page":"161","volume-title":"Multiclass alternating decision trees. 12th European Conference on Machine Learning; September 5\u20137; Freiburg, Germany","author":"G Holmes","year":"2001","unstructured":"Holmes G, Pfahringer B, Kirkby R, Frank E, Hall M. Multiclass alternating decision trees. 12th European Conference on Machine Learning; September 5\u20137; Freiburg, Germany. 2001. p. 161\u201372."},{"issue":"1\u20132","key":"173_CR111","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10994-005-0466-3","volume":"95","author":"N Landwehr","year":"2005","unstructured":"Landwehr N, Hall M, Frank E. Logistic model trees. Mach Learn. 2005;95(1\u20132):161\u2013205.","journal-title":"Mach Learn"},{"key":"173_CR112","volume-title":"Classification and regression trees","author":"L Breiman","year":"1984","unstructured":"Breiman L, Friedman JH, Olshen RA, Stone CJ. Classification and regression trees. Boca Rat\u00f3n, FL: Chapman and Hall\/CRC Press; 1984."},{"key":"173_CR113","first-page":"148","volume-title":"Experiments with a new boosting algorithm. Thirteenth International Conference on Machine Learning; July 3\u20136; Bari, Italy","author":"Y Freund","year":"1996","unstructured":"Freund Y, Schapire RE. Experiments with a new boosting algorithm. Thirteenth International Conference on Machine Learning; July 3\u20136; Bari, Italy. 1996. p. 148\u201356."},{"issue":"1","key":"173_CR114","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1023\/A:1007421302149","volume":"32","author":"E Frank","year":"1998","unstructured":"Frank E, Wang Y, Inglis S, Holmes G, Witten I. Using model trees for classification. Mach Learn. 1998;32(1):63\u201376. doi: 10.1023\/a:1007421302149 .","journal-title":"Mach Learn"},{"issue":"1","key":"173_CR115","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.inffus.2004.04.001","volume":"6","author":"P Melville","year":"2005","unstructured":"Melville P, Mooney RJ. Creating diversity in ensembles using artificial data. Information Fusion. 2005;6(1):99\u2013111. http:\/\/dx.doi.org\/10.1016\/j.inffus.2004.04.001 .","journal-title":"Information Fusion"},{"key":"173_CR116","first-page":"505","volume-title":"Constructing diverse classifier ensembles using artificial training examples. Eighteenth International Joint Conference on Artificial Intelligence; August 9\u201315; Acapulco, Mexico","author":"P Melville","year":"2003","unstructured":"Melville P, Mooney RJ. Constructing diverse classifier ensembles using artificial training examples. Eighteenth International Joint Conference on Artificial Intelligence; August 9\u201315; Acapulco, Mexico. 2003. p. 505\u201310."},{"issue":"6","key":"173_CR117","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/j.neurobiolaging.2012.12.020","volume":"34","author":"L Brighina","year":"2013","unstructured":"Brighina L, Riva C, Bertola F, Saracchi E, Fermi S, Goldwurm S, et al. Analysis of vesicular monoamine transporter 2 polymorphisms in Parkinson\u2019s disease. Neurobiol Aging. 2013;34(6):1712. e9-13. doi: 10.1016\/j.neurobiolaging.2012.12.020 .","journal-title":"Neurobiol Aging"},{"issue":"9","key":"173_CR118","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00702-010-0446-z","volume":"117","author":"G Sala","year":"2010","unstructured":"Sala G, Brighina L, Saracchi E, Fermi S, Riva C, Carrozza V, et al. Vesicular monoamine transporter 2 mRNA levels are reduced in platelets from patients with Parkinson\u2019s disease. J Neural Transm. 2010;117(9):1093\u20138. doi: 10.1007\/s00702-010-0446-z .","journal-title":"J Neural Transm"},{"issue":"7","key":"173_CR119","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s11910-013-0362-3","volume":"13","author":"SP Alter","year":"2013","unstructured":"Alter SP, Lenzi GM, Bernstein AI, Miller GW. Vesicular integrity in Parkinson\u2019s disease. Curr Neurol Neurosci Rep. 2013;13(7):362. doi: 10.1007\/s11910-013-0362-3 .","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"6","key":"173_CR120","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1056\/NEJMoa1207281","volume":"368","author":"JJ Rilstone","year":"2013","unstructured":"Rilstone JJ, Alkhater RA, Minassian BA. Brain dopamine-serotonin vesicular transport disease and its treatment. New Engl J Med. 2013;368(6):543\u201350. doi: 10.1056\/NEJMoa1207281 .","journal-title":"New Engl J Med"},{"key":"173_CR121","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1196\/annals.1344.031","volume":"1053","author":"S Mandel","year":"2005","unstructured":"Mandel S, Grunblatt E, Riederer P, Amariglio N, Jacob-Hirsch J, Rechavi G, et al. Gene expression profiling of sporadic Parkinson\u2019s disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70. Ann N Y Acad Sci. 2005;1053:356\u201375. doi: 10.1196\/annals.1344.031 .","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"173_CR122","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2967\/jnumed.109.070094","volume":"51","author":"N Okamura","year":"2010","unstructured":"Okamura N, Villemagne VL, Drago J, Pejoska S, Dhamija RK, Mulligan RS, et al. In vivo measurement of vesicular monoamine transporter type 2 density in Parkinson disease with (18)F-AV-133. J Nucl Med. 2010;51(2):223\u20138. doi: 10.2967\/jnumed.109.070094 .","journal-title":"J Nucl Med"},{"issue":"3","key":"173_CR123","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/ana.21320","volume":"63","author":"WR Martin","year":"2008","unstructured":"Martin WR, Wieler M, Stoessl AJ, Schulzer M. Dihydrotetrabenazine positron emission tomography imaging in early, untreated Parkinson\u2019s disease. Ann Neurol. 2008;63(3):388\u201394. doi: 10.1002\/ana.21320 .","journal-title":"Ann Neurol"},{"issue":"4","key":"173_CR124","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/1531-8249(200004)47:4<493::AID-ANA13>3.0.CO;2-4","volume":"47","author":"CS Lee","year":"2000","unstructured":"Lee CS, Samii A, Sossi V, Ruth TJ, Schulzer M, Holden JE, et al. In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson\u2019s disease. Ann Neurol. 2000;47(4):493\u2013503.","journal-title":"Ann Neurol"},{"issue":"9","key":"173_CR125","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/sj.jcbfm.9600276","volume":"26","author":"NI Bohnen","year":"2006","unstructured":"Bohnen NI, Albin RL, Koeppe RA, Wernette KA, Kilbourn MR, Minoshima S, et al. Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease. J Cereb Blood Flow Metab. 2006;26(9):1198\u2013212. doi: 10.1038\/sj.jcbfm.9600276 .","journal-title":"J Cereb Blood Flow Metab"},{"key":"173_CR126","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neuint.2013.12.003","volume":"73","author":"AI Bernstein","year":"2014","unstructured":"Bernstein AI, Stout KA, Miller GW. The vesicular monoamine transporter 2: an underexplored pharmacological target. Neurochem Int. 2014;73:89\u201397. doi: 10.1016\/j.neuint.2013.12.003 .","journal-title":"Neurochem Int"},{"key":"173_CR127","volume-title":"Diagnostic test for parkinson\u2019s disease. Google Patents","author":"E Grunblatt","year":"2005","unstructured":"Grunblatt E, Mandel SA, Riederer P, Youdim MBH. Diagnostic test for parkinson\u2019s disease. Google Patents. 2005."},{"issue":"3","key":"173_CR128","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.nbd.2007.02.009","volume":"26","author":"I Cantuti-Castelvetri","year":"2007","unstructured":"Cantuti-Castelvetri I, Keller-McGandy C, Bouzou B, Asteris G, Clark TW, Frosch MP, et al. Effects of gender on nigral gene expression and parkinson disease. Neurobiol Dis. 2007;26(3):606\u201314. doi: 10.1016\/j.nbd.2007.02.009 .","journal-title":"Neurobiol Dis"},{"issue":"1","key":"173_CR129","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1750-3639.2008.00171.x","volume":"19","author":"K Bossers","year":"2009","unstructured":"Bossers K, Meerhoff G, Balesar R, van Dongen JW, Kruse CG, Swaab DF, et al. Analysis of gene expression in Parkinson\u2019s disease: possible involvement of neurotrophic support and axon guidance in dopaminergic cell death. Brain Pathol. 2009;19(1):91\u2013107. doi: 10.1111\/j.1750-3639.2008.00171.x .","journal-title":"Brain Pathol"},{"key":"173_CR130","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.expneurol.2013.10.014","volume":"250","author":"PK Sonsalla","year":"2013","unstructured":"Sonsalla PK, Coleman C, Wong LY, Harris SL, Richardson JR, Gadad BS, et al. The angiotensin converting enzyme inhibitor captopril protects nigrostriatal dopamine neurons in animal models of parkinsonism. Exp Neurol. 2013;250:376\u201383. doi: 10.1016\/j.expneurol.2013.10.014 .","journal-title":"Exp Neurol"},{"issue":"4","key":"173_CR131","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.neurobiolaging.2006.02.018","volume":"28","author":"P Rey","year":"2007","unstructured":"Rey P, Lopez-Real A, Sanchez-Iglesias S, Munoz A, Soto-Otero R, Labandeira-Garcia JL. Angiotensin type-1-receptor antagonists reduce 6-hydroxydopamine toxicity for dopaminergic neurons. Neurobiol Aging. 2007;28(4):555\u201367. doi: 10.1016\/j.neurobiolaging.2006.02.018 .","journal-title":"Neurobiol Aging"},{"issue":"1","key":"173_CR132","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neuropharm.2006.03.004","volume":"51","author":"A Munoz","year":"2006","unstructured":"Munoz A, Rey P, Guerra MJ, Mendez-Alvarez E, Soto-Otero R, Labandeira-Garcia JL. Reduction of dopaminergic degeneration and oxidative stress by inhibition of angiotensin converting enzyme in a MPTP model of parkinsonism. Neuropharmacology. 2006;51(1):112\u201320. doi: 10.1016\/j.neuropharm.2006.03.004 .","journal-title":"Neuropharmacology"},{"issue":"1","key":"173_CR133","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.euroneuro.2004.05.007","volume":"15","author":"R Kurosaki","year":"2005","unstructured":"Kurosaki R, Muramatsu Y, Kato H, Watanabe Y, Imai Y, Itoyama Y, et al. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice. Eur Neuropsychopharmacol. 2005;15(1):57\u201367. doi: 10.1016\/j.euroneuro.2004.05.007 .","journal-title":"Eur Neuropsychopharmacol"},{"issue":"6","key":"173_CR134","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/jnr.20598","volume":"81","author":"A Lopez-Real","year":"2005","unstructured":"Lopez-Real A, Rey P, Soto-Otero R, Mendez-Alvarez E, Labandeira-Garcia JL. Angiotensin-converting enzyme inhibition reduces oxidative stress and protects dopaminergic neurons in a 6-hydroxydopamine rat model of Parkinsonism. J Neurosci Res. 2005;81(6):865\u201373. doi: 10.1002\/jnr.20598 .","journal-title":"J Neurosci Res"},{"issue":"1","key":"173_CR135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psyneuen.2010.10.001","volume":"36","author":"JM Saavedra","year":"2011","unstructured":"Saavedra JM, Sanchez-Lemus E, Benicky J. Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: therapeutic implications. Psychoneuroendocrinology. 2011;36(1):1\u201318. doi: 10.1016\/j.psyneuen.2010.10.001 .","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"173_CR136","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1471-4159.2009.05999.x","volume":"109","author":"B Joglar","year":"2009","unstructured":"Joglar B, Rodriguez-Pallares J, Rodriguez-Perez AI, Rey P, Guerra MJ, Labandeira-Garcia JL. The inflammatory response in the MPTP model of Parkinson\u2019s disease is mediated by brain angiotensin: relevance to progression of the disease. J Neurochem. 2009;109(2):656\u201369. doi: 10.1111\/j.1471-4159.2009.05999.x .","journal-title":"J Neurochem"},{"issue":"12","key":"173_CR137","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s00702-004-0212-1","volume":"111","author":"E Grunblatt","year":"2004","unstructured":"Grunblatt E, Mandel S, Jacob-Hirsch J, Zeligson S, Amariglo N, Rechavi G, et al. Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion\/cellular matrix and vesicle trafficking genes. J Neural Transm. 2004;111(12):1543\u201373. doi: 10.1007\/s00702-004-0212-1 .","journal-title":"J Neural Transm"},{"issue":"3","key":"173_CR138","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.febslet.2008.12.055","volume":"583","author":"J Fukae","year":"2009","unstructured":"Fukae J, Sato S, Shiba K, Sato K, Mori H, Sharp PA, et al. Programmed cell death-2 isoform1 is ubiquitinated by parkin and increased in the substantia nigra of patients with autosomal recessive Parkinson\u2019s disease. FEBS Lett. 2009;583(3):521\u20135. doi: 10.1016\/j.febslet.2008.12.055 .","journal-title":"FEBS Lett"},{"key":"173_CR139","first-page":"214714","volume":"2012","author":"PF Durrenberger","year":"2012","unstructured":"Durrenberger PF, Grunblatt E, Fernando FS, Monoranu CM, Evans J, Riederer P, et al. Inflammatory pathways in Parkinson\u2019s disease; a BNE microarray study. Parkinsons Dis. 2012;2012:214714. doi: 10.1155\/2012\/214714 .","journal-title":"Parkinsons Dis"},{"key":"173_CR140","volume-title":"Peripheral blood gene markers for early diagnosis of parkinson\u2019s disease. Google Patents","author":"SA Mandel","year":"2013","unstructured":"Mandel SA, Youdim MBH, Riederer P, Grunblatt E, Rabey JM, Molochnikov L. Peripheral blood gene markers for early diagnosis of parkinson\u2019s disease. Google Patents. 2013."},{"issue":"23","key":"173_CR141","doi-asserted-by":"crossref","first-page":"13650","DOI":"10.1073\/pnas.2232515100","volume":"100","author":"PD Smith","year":"2003","unstructured":"Smith PD, Crocker SJ, Jackson-Lewis V, Jordan-Sciutto KL, Hayley S, Mount MP, et al. Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson\u2019s disease. Proc Natl Acad Sci U S A. 2003;100(23):13650\u20135. doi: 10.1073\/pnas.2232515100 .","journal-title":"Proc Natl Acad Sci U S A"},{"key":"173_CR142","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neulet.2013.10.060","volume":"564","author":"D Zhai","year":"2014","unstructured":"Zhai D, Li S, Zhao Y, Lin Z. SLC6A3 is a risk factor for Parkinson\u2019s disease: a meta-analysis of sixteen years\u2019 studies. Neurosci Lett. 2014;564:99\u2013104. doi: 10.1016\/j.neulet.2013.10.060 .","journal-title":"Neurosci Lett"},{"issue":"14","key":"173_CR143","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1242\/dev.037556","volume":"136","author":"FM Jacobs","year":"2009","unstructured":"Jacobs FM, van der Linden AJ, Wang Y, von Oerthel L, Sul HS, Burbach JP, et al. Identification of Dlk1, Ptpru and Klhl1 as novel Nurr1 target genes in meso-diencephalic dopamine neurons. Development. 2009;136(14):2363\u201373. doi: 10.1242\/dev.037556 .","journal-title":"Development"},{"issue":"8","key":"173_CR144","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.4049\/jimmunol.154.8.3871","volume":"154","author":"T Okabe","year":"1995","unstructured":"Okabe T, Takayanagi R, Imasaki K, Haji M, Nawata H, Watanabe T. cDNA cloning of a NGFI-B\/nur77-related transcription factor from an apoptotic human T cell line. J Immunol. 1995;154(8):3871\u20139.","journal-title":"J Immunol"},{"issue":"6","key":"173_CR145","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1212\/WNL.58.6.881","volume":"58","author":"PY Xu","year":"2002","unstructured":"Xu PY, Liang R, Jankovic J, Hunter C, Zeng YX, Ashizawa T, et al. Association of homozygous 7048G7049 variant in the intron six of Nurr1 gene with Parkinson\u2019s disease. Neurology. 2002;58(6):881\u20134.","journal-title":"Neurology"},{"issue":"1","key":"173_CR146","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ajmg.b.20033","volume":"120B","author":"A Carmine","year":"2003","unstructured":"Carmine A, Buervenich S, Galter D, Jonsson EG, Sedvall GC, Farde L, et al. NURR1 promoter polymorphisms: Parkinson\u2019s disease, schizophrenia, and personality traits. Am J Med Genet B Neuropsychiatr Genet. 2003;120B(1):51\u20137. doi: 10.1002\/ajmg.b.20033 .","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"1","key":"173_CR147","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/ng1066","volume":"33","author":"WD Le","year":"2003","unstructured":"Le WD, Xu P, Jankovic J, Jiang H, Appel SH, Smith RG, et al. Mutations in NR4A2 associated with familial Parkinson disease. Nat Genet. 2003;33(1):85\u20139. doi: 10.1038\/ng1066 .","journal-title":"Nat Genet"},{"issue":"3","key":"173_CR148","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0304-3940(03)00539-1","volume":"347","author":"EK Tan","year":"2003","unstructured":"Tan EK, Chung H, Zhao Y, Shen H, Chandran VR, Tan C, et al. Genetic analysis of Nurr1 haplotypes in Parkinson\u2019s disease. Neurosci Lett. 2003;347(3):139\u201342.","journal-title":"Neurosci Lett"},{"issue":"5","key":"173_CR149","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/archneur.60.5.722","volume":"60","author":"K Zheng","year":"2003","unstructured":"Zheng K, Heydari B, Simon DK. A common NURR1 polymorphism associated with Parkinson disease and diffuse Lewy body disease. Arch Neurol. 2003;60(5):722\u20135. doi: 10.1001\/archneur.60.5.722 .","journal-title":"Arch Neurol"},{"issue":"11","key":"173_CR150","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1212\/01.WNL.0000127496.23198.75","volume":"62","author":"P Ibanez","year":"2004","unstructured":"Ibanez P, Lohmann E, Pollak P, Durif F, Tranchant C, Agid Y, et al. Absence of NR4A2 exon 1 mutations in 108 families with autosomal dominant Parkinson disease. Neurology. 2004;62(11):2133\u20134.","journal-title":"Neurology"},{"issue":"2","key":"173_CR151","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.neulet.2004.05.028","volume":"366","author":"C Levecque","year":"2004","unstructured":"Levecque C, Destee A, Mouroux V, Amouyel P, Chartier-Harlin MC. Assessment of Nurr1 nucleotide variations in familial Parkinson\u2019s disease. Neurosci Lett. 2004;366(2):135\u20138. doi: 10.1016\/j.neulet.2004.05.028 .","journal-title":"Neurosci Lett"},{"issue":"6","key":"173_CR152","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/mds.20097","volume":"19","author":"WC Nichols","year":"2004","unstructured":"Nichols WC, Uniacke SK, Pankratz N, Reed T, Simon DK, Halter C, et al. Evaluation of the role of Nurr1 in a large sample of familial Parkinson\u2019s disease. Mov Disord. 2004;19(6):649\u201355. doi: 10.1002\/mds.20097 .","journal-title":"Mov Disord"},{"issue":"12","key":"173_CR153","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1002\/mds.20246","volume":"19","author":"EK Tan","year":"2004","unstructured":"Tan EK, Chung H, Chandran VR, Tan C, Shen H, Yew K, et al. Nurr1 mutational screen in Parkinson\u2019s disease. Mov Disord. 2004;19(12):1503\u20135. doi: 10.1002\/mds.20246 .","journal-title":"Mov Disord"},{"issue":"3","key":"173_CR154","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/cne.20828","volume":"494","author":"Y Chu","year":"2006","unstructured":"Chu Y, Le W, Kompoliti K, Jankovic J, Mufson EJ, Kordower JH. Nurr1 in Parkinson\u2019s disease and related disorders. J Comp Neurol. 2006;494(3):495\u2013514. doi: 10.1002\/cne.20828 .","journal-title":"J Comp Neurol"},{"issue":"7","key":"173_CR155","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/mds.20820","volume":"21","author":"DA Grimes","year":"2006","unstructured":"Grimes DA, Han F, Panisset M, Racacho L, Xiao F, Zou R, et al. Translated mutation in the Nurr1 gene as a cause for Parkinson\u2019s disease. Mov Disord. 2006;21(7):906\u20139. doi: 10.1002\/mds.20820 .","journal-title":"Mov Disord"},{"issue":"11","key":"173_CR156","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1002\/mds.21018","volume":"21","author":"DG Healy","year":"2006","unstructured":"Healy DG, Abou-Sleiman PM, Ahmadi KR, Gandhi S, Muqit MM, Bhatia KP, et al. NR4A2 genetic variation in sporadic Parkinson\u2019s disease: a genewide approach. Mov Disord. 2006;21(11):1960\u20133. doi: 10.1002\/mds.21018 .","journal-title":"Mov Disord"},{"issue":"4","key":"173_CR157","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/ajmg.b.30476","volume":"144B","author":"CM Chen","year":"2007","unstructured":"Chen CM, Chen IC, Chang KH, Chen YC, Lyu RK, Liu YT, et al. Nuclear receptor NR4A2 IVS6\u2009+\u200918insG and brain derived neurotrophic factor (BDNF) V66M polymorphisms and risk of Taiwanese Parkinson\u2019s disease. Am J Med Genet B Neuropsychiatr Genet. 2007;144B(4):458\u201362. doi: 10.1002\/ajmg.b.30476 .","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"1\u20132","key":"173_CR158","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jns.2008.06.007","volume":"273","author":"W Le","year":"2008","unstructured":"Le W, Pan T, Huang M, Xu P, Xie W, Zhu W, et al. Decreased NURR1 gene expression in patients with Parkinson\u2019s disease. J Neurol Sci. 2008;273(1\u20132):29\u201333. doi: 10.1016\/j.jns.2008.06.007 .","journal-title":"J Neurol Sci"},{"issue":"6","key":"173_CR159","first-page":"693","volume":"25","author":"Y Wu","year":"2008","unstructured":"Wu Y, Peng R, Chen W, Zhang J, Li T, Wang Y, et al. Association of the polymorphisms in NURR1 gene with Parkinson\u2019s disease. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2008;25(6):693\u20136.","journal-title":"Zhonghua Yi Xue Yi Chuan Xue Za Zhi"},{"issue":"2","key":"173_CR160","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.neulet.2009.03.021","volume":"457","author":"PM Sleiman","year":"2009","unstructured":"Sleiman PM, Healy DG, Muqit MM, Yang YX, Van Der Brug M, Holton JL, et al. Characterisation of a novel NR4A2 mutation in Parkinson\u2019s disease brain. Neurosci Lett. 2009;457(2):75\u20139. doi: 10.1016\/j.neulet.2009.03.021 .","journal-title":"Neurosci Lett"},{"issue":"27","key":"173_CR161","doi-asserted-by":"crossref","first-page":"9248","DOI":"10.1523\/JNEUROSCI.1731-12.2012","volume":"32","author":"X Lin","year":"2012","unstructured":"Lin X, Parisiadou L, Sgobio C, Liu G, Yu J, Sun L, et al. Conditional expression of Parkinson\u2019s disease-related mutant alpha-synuclein in the midbrain dopaminergic neurons causes progressive neurodegeneration and degradation of transcription factor nuclear receptor related 1. J Neurosci. 2012;32(27):9248\u201364. doi: 10.1523\/jneurosci.1731-12.2012 .","journal-title":"J Neurosci"},{"issue":"6","key":"173_CR162","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/j.1468-1331.2011.03644.x","volume":"19","author":"H Liu","year":"2012","unstructured":"Liu H, Wei L, Tao Q, Deng H, Ming M, Xu P, et al. Decreased NURR1 and PITX3 gene expression in Chinese patients with Parkinson\u2019s disease. Eur J Neurol. 2012;19(6):870\u20135. doi: 10.1111\/j.1468-1331.2011.03644.x .","journal-title":"Eur J Neurol"},{"issue":"3","key":"173_CR163","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1468-1331.2012.03824.x","volume":"20","author":"H Liu","year":"2013","unstructured":"Liu H, Tao Q, Deng H, Ming M, Ding Y, Xu P, et al. Genetic analysis of NR4A2 gene in a large population of Han Chinese patients with Parkinson\u2019s disease. Eur J Neurol. 2013;20(3):584\u20137. doi: 10.1111\/j.1468-1331.2012.03824.x .","journal-title":"Eur J Neurol"},{"issue":"7708","key":"173_CR164","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0140-6736(71)91608-4","volume":"1","author":"WE Martin","year":"1971","unstructured":"Martin WE. Tyrosine hydroxylase deficiency. A unifying concept of Parkinsonism. Lancet. 1971;1(7708):1050\u20131.","journal-title":"Lancet"},{"issue":"3","key":"173_CR165","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF02741387","volume":"16","author":"J Haavik","year":"1998","unstructured":"Haavik J, Toska K. Tyrosine hydroxylase and Parkinson\u2019s disease. Mol Neurobiol. 1998;16(3):285\u2013309. doi: 10.1007\/bf02741387 .","journal-title":"Mol Neurobiol"},{"issue":"4","key":"173_CR166","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2174\/187152712800792785","volume":"11","author":"S Tabrez","year":"2012","unstructured":"Tabrez S, Jabir NR, Shakil S, Greig NH, Alam Q, Abuzenadah AM, et al. A synopsis on the role of tyrosine hydroxylase in Parkinson\u2019s disease. CNS Neurol Disord Drug Targets. 2012;11(4):395\u2013409.","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"4","key":"173_CR167","doi-asserted-by":"crossref","first-page":"350","DOI":"10.2174\/187152712800792901","volume":"11","author":"Y Zhu","year":"2012","unstructured":"Zhu Y, Zhang J, Zeng Y. Overview of tyrosine hydroxylase in Parkinson\u2019s disease. CNS Neurol Disord Drug Targets. 2012;11(4):350\u20138.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"173_CR168","doi-asserted-by":"crossref","DOI":"10.5936\/csbj.201304004","volume":"7","author":"S Chandrasekaran","year":"2013","unstructured":"Chandrasekaran S, Bonchev D. A network view on Parkinson\u2019s disease. Comput Struct Biotechnol J. 2013;7, e201304004. doi: 10.5936\/csbj.201304004 .","journal-title":"Comput Struct Biotechnol J"},{"issue":"11","key":"173_CR169","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1634\/stemcells.2006-0119","volume":"24","author":"L Lin","year":"2006","unstructured":"Lin L, Isacson O. Axonal growth regulation of fetal and embryonic stem cell-derived dopaminergic neurons by Netrin-1 and Slits. Stem Cells. 2006;24(11):2504\u201313. doi: 10.1634\/stemcells.2006-0119 .","journal-title":"Stem Cells"},{"issue":"2","key":"173_CR170","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1523\/JNEUROSCI.5303-08.2009","volume":"29","author":"W Chatoo","year":"2009","unstructured":"Chatoo W, Abdouh M, David J, Champagne MP, Ferreira J, Rodier F, et al. The polycomb group gene Bmi1 regulates antioxidant defenses in neurons by repressing p53 pro-oxidant activity. J Neurosci. 2009;29(2):529\u201342. doi: 10.1523\/jneurosci.5303-08.2009 .","journal-title":"J Neurosci"},{"key":"173_CR171","doi-asserted-by":"crossref","first-page":"R183","DOI":"10.1093\/hmg\/ddm159","volume":"16 Spec No. 2","author":"B Thomas","year":"2007","unstructured":"Thomas B, Beal MF. Parkinson\u2019s disease. Hum Mol Genet. 2007;16 Spec No. 2:R183\u201394. doi: 10.1093\/hmg\/ddm159 .","journal-title":"Hum Mol Genet"},{"issue":"26","key":"173_CR172","doi-asserted-by":"crossref","first-page":"14512","DOI":"10.1073\/pnas.94.26.14512","volume":"94","author":"MT Johnson","year":"1997","unstructured":"Johnson MT, Yang HS, Magnuson T, Patel MS. Targeted disruption of the murine dihydrolipoamide dehydrogenase gene (Dld) results in perigastrulation lethality. Proc Natl Acad Sci U S A. 1997;94(26):14512\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"173_CR173","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1046\/j.1471-4159.2003.02263.x","volume":"88","author":"P Klivenyi","year":"2004","unstructured":"Klivenyi P, Starkov AA, Calingasan NY, Gardian G, Browne SE, Yang L, et al. Mice deficient in dihydrolipoamide dehydrogenase show increased vulnerability to MPTP, malonate and 3-nitropropionic acid neurotoxicity. J Neurochem. 2004;88(6):1352\u201360.","journal-title":"J Neurochem"},{"key":"173_CR174","first-page":"11","volume":"20","author":"P Jenner","year":"1986","unstructured":"Jenner P, Marsden CD. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson\u2019s disease. J Neural Transm Suppl. 1986;20:11\u201339.","journal-title":"J Neural Transm Suppl"},{"issue":"2","key":"173_CR175","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0197-0186(99)00114-X","volume":"36","author":"GE Gibson","year":"2000","unstructured":"Gibson GE, Park LC, Sheu KF, Blass JP, Calingasan NY. The alpha-ketoglutarate dehydrogenase complex in neurodegeneration. Neurochem Int. 2000;36(2):97\u2013112.","journal-title":"Neurochem Int"},{"issue":"2","key":"173_CR176","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0197-0186(02)00225-5","volume":"43","author":"GE Gibson","year":"2003","unstructured":"Gibson GE, Kingsbury AE, Xu H, Lindsay JG, Daniel S, Foster OJ, et al. Deficits in a tricarboxylic acid cycle enzyme in brains from patients with Parkinson\u2019s disease. Neurochem Int. 2003;43(2):129\u201335.","journal-title":"Neurochem Int"},{"issue":"1","key":"173_CR177","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0022-510X(90)90056-S","volume":"96","author":"Y Mizuno","year":"1990","unstructured":"Mizuno Y, Suzuki K, Ohta S. Postmortem changes in mitochondrial respiratory enzymes in brain and a preliminary observation in Parkinson\u2019s disease. J Neurol Sci. 1990;96(1):49\u201357.","journal-title":"J Neurol Sci"},{"issue":"3","key":"173_CR178","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3727\/000000006783991827","volume":"13","author":"S Papapetropoulos","year":"2006","unstructured":"Papapetropoulos S, Ffrench-Mullen J, McCorquodale D, Qin Y, Pablo J, Mash DC. Multiregional gene expression profiling identifies MRPS6 as a possible candidate gene for Parkinson\u2019s disease. Gene Expr. 2006;13(3):205\u201315.","journal-title":"Gene Expr"},{"key":"173_CR179","volume-title":"Gene expression profiling of Parkinson\u2019s Disease. Google Patents","author":"S Papapetropoulos","year":"2012","unstructured":"Papapetropoulos S, Ffrench-Mullen J, Mash DC. Gene expression profiling of Parkinson\u2019s Disease. Google Patents. 2012."},{"key":"173_CR180","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1749-8104-7-24","volume":"7","author":"P Sgado","year":"2012","unstructured":"Sgado P, Ferretti E, Grbec D, Bozzi Y, Simon HH. The atypical homeoprotein Pbx1a participates in the axonal pathfinding of mesencephalic dopaminergic neurons. Neural Dev. 2012;7:24. doi: 10.1186\/1749-8104-7-24 .","journal-title":"Neural Dev"},{"issue":"6","key":"173_CR181","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1212\/WNL.48.6.1589","volume":"48","author":"V Plante-Bordeneuve","year":"1997","unstructured":"Plante-Bordeneuve V, Taussig D, Thomas F, Said G, Wood NW, Marsden CD, et al. Evaluation of four candidate genes encoding proteins of the dopamine pathway in familial and sporadic Parkinson\u2019s disease: evidence for association of a DRD2 allele. Neurology. 1997;48(6):1589\u201393.","journal-title":"Neurology"},{"issue":"3","key":"173_CR182","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0304-3940(99)00633-3","volume":"273","author":"P Pastor","year":"1999","unstructured":"Pastor P, Munoz E, Obach V, Marti MJ, Blesa R, Oliva R, et al. Dopamine receptor D2 intronic polymorphism in patients with Parkinson\u2019s disease. Neurosci Lett. 1999;273(3):151\u20134.","journal-title":"Neurosci Lett"},{"issue":"4","key":"173_CR183","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/jnnp.69.4.535","volume":"69","author":"P Costa-Mallen","year":"2000","unstructured":"Costa-Mallen P, Costa LG, Smith-Weller T, Franklin GM, Swanson PD, Checkoway H. Genetic polymorphism of dopamine D2 receptors in Parkinson\u2019s disease and interactions with cigarette smoking and MAO-B intron 13 polymorphism. J Neurol Neurosurg Psychiatry. 2000;69(4):535\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"173_CR184","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/1531-8257(200011)15:6<1070::AID-MDS1003>3.0.CO;2-A","volume":"15","author":"L Grevle","year":"2000","unstructured":"Grevle L, Guzey C, Hadidi H, Brennersted R, Idle JR, Aasly J. Allelic association between the DRD2 TaqI A polymorphism and Parkinson\u2019s disease. Mov Disord. 2000;15(6):1070\u20134.","journal-title":"Mov Disord"},{"issue":"1","key":"173_CR185","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/1531-8257(200001)15:1<120::AID-MDS1019>3.0.CO;2-S","volume":"15","author":"RL Oliveri","year":"2000","unstructured":"Oliveri RL, Annesi G, Zappia M, Civitelli D, De Marco EV, Pasqua AA, et al. The dopamine D2 receptor gene is a susceptibility locus for Parkinson\u2019s disease. Mov Disord. 2000;15(1):127\u201331.","journal-title":"Mov Disord"},{"issue":"4\u20135","key":"173_CR186","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0161-813X(02)00061-X","volume":"23","author":"SN Kelada","year":"2002","unstructured":"Kelada SN, Costa-Mallen P, Costa LG, Smith-Weller T, Franklin GM, Swanson PD, et al. Gender difference in the interaction of smoking and monoamine oxidase B intron 13 genotype in Parkinson\u2019s disease. Neurotoxicology. 2002;23(4\u20135):515\u20139.","journal-title":"Neurotoxicology"},{"issue":"5","key":"173_CR187","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/mds.10406","volume":"18","author":"EK Tan","year":"2003","unstructured":"Tan EK, Tan Y, Chai A, Tan C, Shen H, Lum SY, et al. Dopamine D2 receptor TaqIA and TaqIB polymorphisms in Parkinson\u2019s disease. Mov Disord. 2003;18(5):593\u20135. doi: 10.1002\/mds.10406 .","journal-title":"Mov Disord"},{"issue":"1\u20132","key":"173_CR188","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11010-008-9728-2","volume":"312","author":"M Singh","year":"2008","unstructured":"Singh M, Khan AJ, Shah PP, Shukla R, Khanna VK, Parmar D. Polymorphism in environment responsive genes and association with Parkinson disease. Mol Cell Biochem. 2008;312(1\u20132):131\u20138. doi: 10.1007\/s11010-008-9728-2 .","journal-title":"Mol Cell Biochem"},{"issue":"12","key":"173_CR189","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/mds.22678","volume":"24","author":"JY Lee","year":"2009","unstructured":"Lee JY, Lee EK, Park SS, Lim JY, Kim HJ, Kim JS, et al. Association of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson\u2019s disease. Mov Disord. 2009;24(12):1803\u201310. doi: 10.1002\/mds.22678 .","journal-title":"Mov Disord"},{"key":"173_CR190","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1471-2377-11-89","volume":"11","author":"C Kiyohara","year":"2011","unstructured":"Kiyohara C, Miyake Y, Koyanagi M, Fujimoto T, Shirasawa S, Tanaka K, et al. Genetic polymorphisms involved in dopaminergic neurotransmission and risk for Parkinson\u2019s disease in a Japanese population. BMC Neurol. 2011;11:89. doi: 10.1186\/1471-2377-11-89 .","journal-title":"BMC Neurol"},{"issue":"1\u20132","key":"173_CR191","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jns.2011.05.031","volume":"307","author":"V McGuire","year":"2011","unstructured":"McGuire V, Van Den Eeden SK, Tanner CM, Kamel F, Umbach DM, Marder K, et al. Association of DRD2 and DRD3 polymorphisms with Parkinson\u2019s disease in a multiethnic consortium. J Neurol Sci. 2011;307(1\u20132):22\u20139. doi: 10.1016\/j.jns.2011.05.031 .","journal-title":"J Neurol Sci"},{"issue":"1","key":"173_CR192","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/mds.23400","volume":"26","author":"JY Lee","year":"2011","unstructured":"Lee JY, Cho J, Lee EK, Park SS, Jeon BS. Differential genetic susceptibility in diphasic and peak-dose dyskinesias in Parkinson\u2019s disease. Mov Disord. 2011;26(1):73\u20139. doi: 10.1002\/mds.23400 .","journal-title":"Mov Disord"},{"issue":"5","key":"173_CR193","first-page":"436","volume":"50","author":"N Kumudini","year":"2013","unstructured":"Kumudini N, Umai A, Devi YP, Naushad SM, Mridula R, Borgohain R, et al. Impact of COMT H108L, MAOB int 13 A\u2009>\u2009G and DRD2 haplotype on the susceptibility to Parkinson\u2019s disease in South Indian subjects. Indian J Biochem Biophys. 2013;50(5):436\u201341.","journal-title":"Indian J Biochem Biophys"},{"issue":"2","key":"173_CR194","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3892\/br.2014.220","volume":"2","author":"D Dai","year":"2014","unstructured":"Dai D, Wang Y, Wang L, Li J, Ma Q, Tao J, et al. Polymorphisms of and genes and Parkinson\u2019s disease: A meta-analysis. Biomed Rep. 2014;2(2):275\u201381. doi: 10.3892\/br.2014.220 .","journal-title":"Biomed Rep"},{"issue":"41","key":"173_CR195","doi-asserted-by":"crossref","first-page":"15242","DOI":"10.1073\/pnas.0602116103","volume":"103","author":"P Sgado","year":"2006","unstructured":"Sgado P, Alberi L, Gherbassi D, Galasso SL, Ramakers GM, Alavian KN, et al. Slow progressive degeneration of nigral dopaminergic neurons in postnatal Engrailed mutant mice. Proc Natl Acad Sci U S A. 2006;103(41):15242\u20137. doi: 10.1073\/pnas.0602116103 .","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl 2","key":"173_CR196","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1016\/j.parkreldis.2008.04.007","volume":"14","author":"G Pen Le","year":"2008","unstructured":"Le Pen G, Sonnier L, Hartmann A, Bizot JC, Trovero F, Krebs MO, et al. Progressive loss of dopaminergic neurons in the ventral midbrain of adult mice heterozygote for Engrailed1: a new genetic model for Parkinson\u2019s disease? Parkinsonism Relat Disord. 2008;14 Suppl 2:S107\u201311. doi: 10.1016\/j.parkreldis.2008.04.007 .","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"173_CR197","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.neurobiolaging.2009.02.015","volume":"32","author":"D Haubenberger","year":"2011","unstructured":"Haubenberger D, Reinthaler E, Mueller JC, Pirker W, Katzenschlager R, Froehlich R, et al. Association of transcription factor polymorphisms PITX3 and EN1 with Parkinson\u2019s disease. Neurobiol Aging. 2011;32(2):302\u20137. doi: 10.1016\/j.neurobiolaging.2009.02.015 .","journal-title":"Neurobiol Aging"},{"issue":"2\u20133","key":"173_CR198","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jtemb.2012.04.023","volume":"26","author":"S Zoni","year":"2012","unstructured":"Zoni S, Bonetti G, Lucchini R. Olfactory functions at the intersection between environmental exposure to manganese and Parkinsonism. J Trace Elem Med Biol. 2012;26(2\u20133):179\u201382. doi: 10.1016\/j.jtemb.2012.04.023 .","journal-title":"J Trace Elem Med Biol"},{"key":"173_CR199","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1749-8104-6-6","volume":"6","author":"JN Rosenbaum","year":"2011","unstructured":"Rosenbaum JN, Duggan A, Garcia-Anoveros J. Insm1 promotes the transition of olfactory progenitors from apical and proliferative to basal, terminally dividing and neuronogenic. Neural Dev. 2011;6:6. doi: 10.1186\/1749-8104-6-6 .","journal-title":"Neural Dev"},{"issue":"4","key":"173_CR200","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/cne.21629","volume":"507","author":"A Duggan","year":"2008","unstructured":"Duggan A, Madathany T, de Castro SC, Gerrelli D, Guddati K, Garcia-Anoveros J. Transient expression of the conserved zinc finger gene INSM1 in progenitors and nascent neurons throughout embryonic and adult neurogenesis. J Comp Neurol. 2008;507(4):1497\u2013520. doi: 10.1002\/cne.21629 .","journal-title":"J Comp Neurol"},{"issue":"1","key":"173_CR201","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/jnnp.2006.113860","volume":"79","author":"B Westermann","year":"2008","unstructured":"Westermann B, Wattendorf E, Schwerdtfeger U, Husner A, Fuhr P, Gratzl O, et al. Functional imaging of the cerebral olfactory system in patients with Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 2008;79(1):19\u201324. doi: 10.1136\/jnnp.2006.113860 .","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"173_CR202","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1586\/ern.09.115","volume":"9","author":"A Haehner","year":"2009","unstructured":"Haehner A, Hummel T, Reichmann H. Olfactory dysfunction as a diagnostic marker for Parkinson\u2019s disease. Expert Rev Neurother. 2009;9(12):1773\u20139. doi: 10.1586\/ern.09.115 .","journal-title":"Expert Rev Neurother"},{"issue":"49","key":"173_CR203","doi-asserted-by":"crossref","first-page":"15410","DOI":"10.1523\/JNEUROSCI.1909-09.2009","volume":"29","author":"E Wattendorf","year":"2009","unstructured":"Wattendorf E, Welge-Lussen A, Fiedler K, Bilecen D, Wolfensberger M, Fuhr P, et al. Olfactory impairment predicts brain atrophy in Parkinson\u2019s disease. J Neurosci. 2009;29(49):15410\u20133. doi: 10.1523\/jneurosci.1909-09.2009 .","journal-title":"J Neurosci"},{"issue":"6","key":"173_CR204","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1468-1331.2010.03273.x","volume":"18","author":"CE Teunissen","year":"2011","unstructured":"Teunissen CE, Veerhuis R, De Vente J, Verhey FR, Vreeling F, van Boxtel MP, et al. Brain-specific fatty acid-binding protein is elevated in serum of patients with dementia-related diseases. Eur J Neurol. 2011;18(6):865\u201371. doi: 10.1111\/j.1468-1331.2010.03273.x .","journal-title":"Eur J Neurol"},{"issue":"11","key":"173_CR205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0050297","volume":"5","author":"A Watanabe","year":"2007","unstructured":"Watanabe A, Toyota T, Owada Y, Hayashi T, Iwayama Y, Matsumata M, et al. Fabp7 maps to a quantitative trait locus for a schizophrenia endophenotype. PLoS Biol. 2007;5(11), e297. doi: 10.1371\/journal.pbio.0050297 .","journal-title":"PLoS Biol"},{"issue":"7","key":"173_CR206","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s00213-013-3320-5","volume":"231","author":"SM Grauer","year":"2014","unstructured":"Grauer SM, Hodgson R, Hyde LA. MitoPark mice, an animal model of Parkinson\u2019s disease, show enhanced prepulse inhibition of acoustic startle and no loss of gating in response to the adenosine A(2A) antagonist SCH 412348. Psychopharmacology. 2014;231(7):1325\u201337. doi: 10.1007\/s00213-013-3320-5 .","journal-title":"Psychopharmacology"},{"issue":"1","key":"173_CR207","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3233\/JPD-130307","volume":"4","author":"M Zoetmulder","year":"2014","unstructured":"Zoetmulder M, Biernat HB, Nikolic M, Korbo L, Friberg L, Jennum PJ. Prepulse Inhibition is Associated with Attention, Processing Speed, and\u2009<\u2009sup\u2009>\u2009123<\/sup\u2009>\u2009I-FP-CIT SPECT in Parkinson\u2019s Disease. J Parkinsons Dis. 2014;4(1):77\u201387. doi: 10.3233\/jpd-130307 .","journal-title":"J Parkinsons Dis"},{"issue":"11","key":"173_CR208","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S1474-4422(06)70578-6","volume":"5","author":"HC Fung","year":"2006","unstructured":"Fung HC, Scholz S, Matarin M, Simon-Sanchez J, Hernandez D, Britton A, et al. Genome-wide genotyping in Parkinson\u2019s disease and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol. 2006;5(11):911\u20136. doi: 10.1016\/s1474-4422(06)70578-6 .","journal-title":"Lancet Neurol"},{"issue":"3","key":"173_CR209","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF02918905","volume":"1","author":"N Kitamura","year":"1989","unstructured":"Kitamura N, Hashimoto T, Nishino N, Tanaka C. Inositol 1,4,5-trisphosphate binding sites in the brain: regional distribution, characterization, and alterations in brains of patients with Parkinson\u2019s disease. J Mol Neurosci. 1989;1(3):181\u20137.","journal-title":"J Mol Neurosci"},{"issue":"6","key":"173_CR210","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/nn1700","volume":"9","author":"J Ding","year":"2006","unstructured":"Ding J, Guzman JN, Tkatch T, Chen S, Goldberg JA, Ebert PJ, et al. RGS4-dependent attenuation of M4 autoreceptor function in striatal cholinergic interneurons following dopamine depletion. Nat Neurosci. 2006;9(6):832\u201342. doi: 10.1038\/nn1700 .","journal-title":"Nat Neurosci"},{"issue":"2","key":"173_CR211","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.neuron.2011.11.015","volume":"73","author":"TN Lerner","year":"2012","unstructured":"Lerner TN, Kreitzer AC. RGS4 is required for dopaminergic control of striatal LTD and susceptibility to parkinsonian motor deficits. Neuron. 2012;73(2):347\u201359. doi: 10.1016\/j.neuron.2011.11.015 .","journal-title":"Neuron"},{"key":"173_CR212","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.nbd.2014.06.013","volume":"70","author":"WK Ko","year":"2014","unstructured":"Ko WK, Martin-Negrier ML, Bezard E, Crossman AR, Ravenscroft P. RGS4 is involved in the generation of abnormal involuntary movements in the unilateral 6-OHDA-lesioned rat model of Parkinson\u2019s disease. Neurobiol Dis. 2014;70:138\u201348. doi: 10.1016\/j.nbd.2014.06.013 .","journal-title":"Neurobiol Dis"},{"issue":"3","key":"173_CR213","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1212\/01.WNL.0000133402.78621.AD","volume":"63","author":"DM Maraganore","year":"2004","unstructured":"Maraganore DM, Wilkes K, Lesnick TG, Strain KJ, de Andrade M, Rocca WA, et al. A limited role for DJ1 in Parkinson disease susceptibility. Neurology. 2004;63(3):550\u20133.","journal-title":"Neurology"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-016-0173-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T22:04:36Z","timestamp":1718402676000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1755-8794\/9\/12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,9]]},"references-count":213,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["173"],"URL":"https:\/\/doi.org\/10.1186\/s12920-016-0173-x","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,9]]},"article-number":"12"}}